Advanced BioHealing, Inc. to Present at Piper Jaffray Health Care Conference and Canaccord Genuity Conference

WESTPORT, Conn., Nov. 29, 2010 /PRNewswire/ -- Advanced BioHealing, Inc. (ABH), a leader in commercializing cell-based therapies and delivering on the promise of regenerative medicine, today announced that company executives will participate in two upcoming investor meetings.

Presentations are scheduled for:

• 22nd Annual Piper Jaffray Health Care Conference -- Nov. 30 - Dec. 1, 2010, in New York City -- Kevin Rakin, Chairman and Chief Executive Officer will discuss Advanced BioHealing's success in commercializing Dermagraft® and highlight future growth opportunities for the Company, on Tuesday, Nov. 30th, beginning at approximately 1:50 p.m. ET.

• Canaccord Genuity Fifth Annual Cardiovascular, Diabetes & Obesity ConferenceDec. 7 - 8, 2010 at the Nikko Hotel in San Francisco -- Dean Tozer, Senior Vice President, will provide a corporate profile on Wednesday, Dec. 8that approximately 9:30 a.m. PT, highlighting Advanced BioHealing's lead product, Dermagraft, an FDA-approved cell-based therapy for the treatment of diabetic foot ulcers.

About Advanced BioHealing, Inc.
Advanced BioHealing develops and commercializes living cell therapies that repair damaged human tissue and enable the body to heal itself. A privately held company, Advanced BioHealing maintains its corporate office in Westport, Conn. with additional sites in La Jolla, Calif. and Nashville, Tenn. To learn more about Advanced BioHealing, please visit the Company's web site at www.ABH.com.

SOURCE Advanced BioHealing, Inc.